Bevacizumab in combination with chemotherapy as first-line therapy in advanced gastric cancer: a biomarker evaluation from the AVAGAST randomized phase III trial (Q84078596)
Jump to navigation
Jump to search
scientific article published on 07 May 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Bevacizumab in combination with chemotherapy as first-line therapy in advanced gastric cancer: a biomarker evaluation from the AVAGAST randomized phase III trial |
scientific article published on 07 May 2012 |
Statements
Bevacizumab in combination with chemotherapy as first-line therapy in advanced gastric cancer: a biomarker evaluation from the AVAGAST randomized phase III trial (English)
Eric Van Cutsem
Sanne de Haas
Yoon-Koo Kang
Niall C Tebbutt
Jian Ming Xu
Wei Peng Yong
Bernd Langer
Stefan J Scherer
Manish A Shah